The use of perfusion CT for the evaluation of therapy combining AZD2171 with gefitinib in cancer pat...
The use of perfusion CT for the evaluation of therapy combining AZD2171 with gefitinib in cancer patients
About this item
Full title
Author / Creator
Publisher
Germany: Springer Nature B.V
Journal title
Language
English
Formats
Publication information
Publisher
Germany: Springer Nature B.V
Subjects
More information
Scope and Contents
Contents
The purpose of this study was to determine the feasibility of dynamic contrast-enhanced perfusion CT (CTP) in evaluating the hemodynamic response of tumors in the chest and abdomen treated with a combination of AZD2171 and gefitinib. Thirteen patients were examined just before and every 4-6 weeks after starting therapy. Following intravenous inject...
Alternative Titles
Full title
The use of perfusion CT for the evaluation of therapy combining AZD2171 with gefitinib in cancer patients
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_3127404077
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3127404077
Other Identifiers
ISSN
0938-7994
E-ISSN
1432-1084
DOI
10.1007/s00330-006-0425-9
